UPDATE 2-DaVita pharmacy unit settles U.S. billing probe for $63.7 million
December 14, 2017 at 16:02 PM EST
Dec 14 (Reuters) - A pharmacy services unit of DaVita Inc will pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said.